Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genpact (G) Cash & Equivalents (2016 - 2026)

Genpact has reported Cash & Equivalents over the past 17 years, most recently at $853.8 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 31.71% year-over-year to $853.8 million; the TTM value through Dec 2025 reached $853.8 million, up 31.71%, while the annual FY2025 figure was $853.8 million, 31.71% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $853.8 million at Genpact, up from $740.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.0 billion in Q3 2024 and troughed at $460.4 million in Q2 2022.
  • A 5-year average of $687.9 million and a median of $647.5 million in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 43.77% in 2022 and later soared 89.03% in 2024.
  • Year by year, Cash & Equivalents stood at $899.5 million in 2021, then decreased by 28.09% to $646.8 million in 2022, then fell by 9.76% to $583.7 million in 2023, then rose by 11.06% to $648.2 million in 2024, then soared by 31.71% to $853.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for G at $853.8 million in Q4 2025, $740.8 million in Q3 2025, and $663.3 million in Q2 2025.